The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.

Completed · Not applicable · Has a placebo group

Conditions studied: Stem Cells

In brief

The goal of the study is to determine the acute and short-term supplementation effect of a commercially available theacrine-containing supplement (NAD3) on numbers of various circulating stem cell populations in older adults.

Key facts

Study ID

NCT06219161

Run by

University of Memphis

People needed

12

Starts

2023-01-02

Expected to finish

2023-07-31

Last updated by the study team

2024-01-23

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or Female
• Age 40-70
• BMI between 21-34.99 kg/m2
• Vital signs with in normal range (heart rate 60-100 beats/minute, blood pressure (40-44 years - 125/83, 45-49 years- 127/84, 50-54 years -129/85, 55-59 years - 131/86, >60 - 134/87), 36.4-37.4 degrees Celsius
• Sedentary to lightly active (2 or fewer days per week of exercise)

You may not qualify if…

• Female participants who are lactating, pregnant or planning to become pregnant during the study
• History of use of illicit drugs or other substances of abuse within 12 months of the screening visit (to be determined at screening)
• Tobacco during the 90 days prior to screening
• Current use of medication/dietary supplements that claim to or have an effect on age-related processes, e.g. "anti-aging" supplements. Participants must undergo a ≥7-day washout period of no supplementation to be eligible.
• Known allergy, intolerance or hypersensitivity to NAD3
• Self-reported active infection or illness of any kind
• Cognitively impaired and/or unable to give informed consent

Where it is running

• The University of Memphis — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.